← All organizations

Highest phase reached
Phase 2
First clinical trial
Feb 1, 2015Last known activity
Dec 31, 2023
Timeline
2010s
- Jun 1, 2014
Actinogen Medical— Founded
- Nov 1, 2014
Corticrine— Acquired
Drugs by trial phase (2 distinct, 6 trials)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (13)
- NCT06125951Lead sponsorPhase 2Dec 31, 2023
- NCT06125951Study directorPhase 2Dec 31, 2023
- NCT05657691Lead sponsorPhase 2Nov 28, 2022
- NCT05657691Study directorPhase 2Nov 28, 2022
- NCT04983368Study directorPhase 1/Phase 2Jun 30, 2021
- NCT04983368Lead sponsorPhase 1/Phase 2Jun 30, 2021
- NCT03830762Lead sponsorPhase 1Jan 21, 2019
- NCT03830762Study chairPhase 1Jan 21, 2019
- NCT02727699Lead sponsorPhase 2Mar 23, 2017
- NCT02727699Study chairPhase 2Mar 23, 2017
- NCT02727699Study directorPhase 2Mar 23, 2017
- NCT02616445Lead sponsorPhase 1Feb 1, 2015
- NCT02616445Study chairPhase 1Feb 1, 2015
Details
- Founded
- Sydney, AU Jun 1, 2014
- Last known activity
- Dec 31, 2023